בעולם הרפואי אין גרסת בטא
פיתוח של תרופה או תכשיר רפואי יכול לעלות עשרות מיליונים. איך עושים את זה נכון על מנת להגדיל את סיכויי ההצלחה?
M.D. Managing General Partner, DFJ Tel Aviv Venture Partners
Co – Chairperson, IATI – Israel Advanced Technology Industries
Managing General Partner DFJ Tel Aviv Venture Partners, Co – Chairperson of Israel Advanced Technology Industries (IATI) and leads the fund Life Science and Cleantech investments
He is a physician specialized in interventional pediatric cardiology.
Prior to joining DFJ TFV in 2003, Dr. Zeevi was the Vice President Business Development & Medical Director of Card Guard AG since 1998.
Founder and Co Director of an Executive Program for Biotechnology and Medical Device Entrepreneurs and Managers, based on International faculty, at the Faculty of Management of Tel-Aviv University and serves on the advisory board of the Faculty of Management at Tel Aviv University.
Chairman of the boards of MGVS, V Wave and ReLeaf, and serves on the board of Kaiima
Served as a professional advisor to several life science companies and venture capital funds while he was still practicing medicine and is a certified Pediatric Cardiologist.
He was Director of Pediatric Catheterization Unit, Schneider Children's Medical Center in Israel.
Dr. Zeevi was a fellow and a visiting Professor and part-time clinical staff at the Children's Hospital, Harvard Medical School in Boston.
His credentials include over 60 peer-reviewed scientific articles, in addition to various chapters in textbooks and invited reviews and editorials in pediatric cardiology journals.
He received the Liberman prize for significant contributions to the evaluation and treatment of children with congenital heart disease.
Dr. Zeevi holds a M.D. degree (Magna Cum Laude) from the Sackler School of Medicine, Tel Aviv University, Israel
Academic director of the Health Care Technological Innovation: From Idea to Commercialization program